CN1296385C - 抗猪生长激素单克隆抗体及制备方法及应用 - Google Patents
抗猪生长激素单克隆抗体及制备方法及应用 Download PDFInfo
- Publication number
- CN1296385C CN1296385C CN 200510016662 CN200510016662A CN1296385C CN 1296385 C CN1296385 C CN 1296385C CN 200510016662 CN200510016662 CN 200510016662 CN 200510016662 A CN200510016662 A CN 200510016662A CN 1296385 C CN1296385 C CN 1296385C
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- variable region
- growth hormone
- pig growth
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 101000868144 Sus scrofa Somatotropin Proteins 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 230000012010 growth Effects 0.000 claims abstract description 16
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 13
- 102000018997 Growth Hormone Human genes 0.000 claims description 21
- 108010051696 Growth Hormone Proteins 0.000 claims description 21
- 230000036039 immunity Effects 0.000 claims description 15
- 238000001514 detection method Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 229960005486 vaccine Drugs 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 210000004408 hybridoma Anatomy 0.000 abstract description 14
- 238000000034 method Methods 0.000 abstract description 11
- 239000000122 growth hormone Substances 0.000 abstract description 6
- 238000012216 screening Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000003248 secreting effect Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 238000011895 specific detection Methods 0.000 abstract description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 238000011896 sensitive detection Methods 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 17
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 239000000427 antigen Substances 0.000 description 16
- 102000036639 antigens Human genes 0.000 description 16
- 108091007433 antigens Proteins 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 13
- 239000000047 product Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 239000005556 hormone Substances 0.000 description 6
- 229940088597 hormone Drugs 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 241000699660 Mus musculus Species 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 239000012228 culture supernatant Substances 0.000 description 3
- 230000024835 cytogamy Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 101710194807 Protective antigen Proteins 0.000 description 2
- 238000002123 RNA extraction Methods 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000003975 animal breeding Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 102220369446 c.1274G>A Human genes 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000007365 immunoregulation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 102220023256 rs387907547 Human genes 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000004988 splenocyte Anatomy 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101710153593 Albumin A Proteins 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102400000368 Surface protein Human genes 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 102220369445 c.668T>C Human genes 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000001728 clone cell Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001652 frontal lobe Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 239000000568 immunological adjuvant Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000010841 mRNA extraction Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 102220023258 rs387907548 Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000007817 turbidimetric assay Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510016662 CN1296385C (zh) | 2005-03-30 | 2005-03-30 | 抗猪生长激素单克隆抗体及制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510016662 CN1296385C (zh) | 2005-03-30 | 2005-03-30 | 抗猪生长激素单克隆抗体及制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1687135A CN1687135A (zh) | 2005-10-26 |
CN1296385C true CN1296385C (zh) | 2007-01-24 |
Family
ID=35305177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510016662 Expired - Fee Related CN1296385C (zh) | 2005-03-30 | 2005-03-30 | 抗猪生长激素单克隆抗体及制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1296385C (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794772B2 (en) | 2004-09-08 | 2010-09-14 | Takasago International Corporation | Concentrated coffee extract and process for producing the same |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516364B (zh) * | 2011-12-26 | 2013-11-06 | 吉林农业大学 | 一种模拟猪生长激素样的活性肽及制备方法与应用 |
EP3171892B1 (en) * | 2014-07-22 | 2021-11-24 | Apollomics Inc. | Anti-pd-1 antibodies |
JP6909153B2 (ja) | 2014-08-05 | 2021-07-28 | アポロミクス インコーポレイテッド | 抗pd−l1抗体 |
-
2005
- 2005-03-30 CN CN 200510016662 patent/CN1296385C/zh not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7794772B2 (en) | 2004-09-08 | 2010-09-14 | Takasago International Corporation | Concentrated coffee extract and process for producing the same |
Also Published As
Publication number | Publication date |
---|---|
CN1687135A (zh) | 2005-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1678744A (zh) | 人的抗人白细胞介素-6抗体以及所述抗体的片段 | |
CN1279168C (zh) | 得到经过修饰降低了鼠抗体可变区之免疫原性的免疫球蛋白的方法及含有免疫球蛋白的组合物 | |
CN1835977A (zh) | Cd20-结合多肽组合物 | |
CN1346371A (zh) | 单克隆抗体、抗原和恶性疾病的诊断和治疗 | |
CN1443199A (zh) | 人mcp-1的抗体 | |
CN1420893A (zh) | 产生人单克隆抗体的方法及组合物 | |
CN1033290A (zh) | 用同源重组技术生产嵌合抗体 | |
CN1639194A (zh) | 抗癌抗体 | |
CN1603345A (zh) | 一种三价双特异性抗体,其制备方法及用途 | |
CN1296385C (zh) | 抗猪生长激素单克隆抗体及制备方法及应用 | |
CN1541266A (zh) | 用于治疗过敏症及哮喘病的Fcε融合蛋白 | |
CN1078494A (zh) | 蛋白质化合物,编码核苷酸序列,产生细胞系和其应用 | |
CN1193353A (zh) | 变应原-xcd32融合蛋白 | |
CN1896102A (zh) | 抗HBsAg单克隆抗体 | |
CN1137726C (zh) | 延长体液免疫抑制的方法 | |
CN1314965C (zh) | 免疫学的测定方法 | |
CN101054416A (zh) | HAb18GC2单抗和其轻、重链可变区基因、编码多肽及应用 | |
CN1418225A (zh) | 人低密度脂蛋白受体的单克隆抗体及其制备和用途 | |
CN101062949A (zh) | 重组抗人IgE单克隆抗体及其制备方法和用途 | |
CN1781944A (zh) | 一种精子蛋白单克隆抗体及其制备方法和用途 | |
CN1911963A (zh) | Sars中和性抗体及应用 | |
CN1175958A (zh) | 单克隆抗独特型抗体(ab2)和其用途 | |
CN1299833A (zh) | 抗人血管内皮生长因子单链抗体及其制备方法 | |
CN1231585C (zh) | 重组鸭白介素2蛋白的制备方法及其用途 | |
CN111303276B (zh) | 旋毛虫肠道期半胱氨酸蛋白酶抑制剂的b细胞表位多肽、杂交瘤细胞株、单克隆抗体、应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WANG ZHE; JILIN AGRICULTURAL UNIVERSITY Free format text: FORMER OWNER: WANG ZHE; ZHENG XIN Effective date: 20070928 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070928 Address after: 130062 No. 175, Xi'an Road, Changchun, Jilin Co-patentee after: Jilin Agricultural University Patentee after: Wang Zhe Address before: 130062 No. 175, Xi'an Road, Changchun, Jilin Co-patentee before: Zheng Xin Patentee before: Wang Zhe |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070124 Termination date: 20110330 |